Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Echinomycin SCHEMBL18506201 | 1.00 | RIPK1 (0.32) | RIPK1 | |
| Echinomycin SCHEMBL13464701 | 1.00 | RIPK1 (0.32) | RIPK1 | |
| Echinomycin SCHEMBL29529894 | 1.00 | RIPK1 (0.32) | RIPK1 | |
| Echinomycin SCHEMBL29420869 | 1.00 | RIPK1 (0.32) | RIPK1 | |
| Echinomycin SCHEMBL30725384 | 1.00 | RIPK1 (0.32) | RIPK1 | |
| Echinomycin SCHEMBL18477111 | 1.00 | RIPK1 (0.32) | RIPK1 | |
| Echinomycin SCHEMBL13928604 | 1.00 | RIPK1 (0.32) | RIPK1 | |
| SCHEMBL20323949 | 0.96 | RIPK1 (0.31) | RIPK1 | |
| SCHEMBL12556535 | 0.95 | RIPK1 (0.31) | RIPK1 | |
| SCHEMBL29378829 | 0.95 | RIPK1 (0.32) | RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4024 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739768-A1 | PROCESS FOR ESTABLISHING A HUMAN TESTICULAR TISSUE CULTURE SYSTEM | Paterna Biosciences Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4676543-A1 | METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND HER2 KINASE INHIBITORS | Seagen Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| WO-2025231217-A1 | COMPOSITIONS AND METHODS OF OLIGONUCLEOTIDE HITCHHIKING FOR ENCAPSULATION OF DRUGS IN LIPID NANOPARTICLES | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2025-11-06 | — | — | WO | claimed |
| EP-4615377-A1 | DRUG-CONTAINING DEVICES, SUPRACHOROIDAL SPACE IMPLANTS, AND ADAPTERS FOR INJECTION | Beijing Sightnovo Medical Technology Co., Ltd (CN) | 2025-09-17 | — | — | EP | claimed |
| CN-120202201-A | Inhibitors of ubiquitin-specific protease 1 and uses thereof | 深圳晶泰科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| US-20250146018-A1 | COMPOSITIONS AND METHODS FOR IMPEDING TRANSCRIPTION OF EXPANDED MICROSATELLITE REPEATS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-05-08 | — | — | US | claimed |
| CN-119868343-A | Anti-glioma pharmaceutical composition and application thereof | 河北大学附属医院 | 2025-04-25 | — | — | CN | claimed |
| US-20250129170-A1 | EPO RECEPTOR AGONISTS AND ANTAGONISTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2025-04-24 | — | — | US | claimed |
| WO-2025054918-A1 | METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND ANTI-PD-1 ANTIBODIES | REMEGEN CO., LTD. (CN) | 2025-03-20 | — | — | WO | claimed |
| WO-2025054916-A1 | METHODS OF TREATING CERVICAL CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES | REMEGEN CO., LTD. (CN) | 2025-03-20 | — | — | WO | claimed |
| US-5204238-A | Binding an antibiotic on or near the star sequences of the restriction enzyme being used for the specific cleavage of DNA | BOEHRINGER MANNHEIM GMBH (DE) | 1993-04-20 | — | — | US | claimed |
| EP-0359347-B1 | COVALENTLY-LINKED COMPLEXES AND METHODS FOR ENHANCED CYTOTOXICITY AND IMAGING | NEORX CORPORATION (US) | 1992-12-23 | — | — | EP | claimed |
| EP-0449178-A2 | Method for the reduction of star activity | Roche Diagnostics GmbH (DE) | 1991-10-02 | — | — | EP | claimed |
| US-5024998-A | Administering in aqueous solution with cyclodextrin derivative | UNIVERSITY OF FLORIDA (US) | 1991-06-18 | — | — | US | claimed |
| US-4983586-A | Decreasing precipitation at injection site or in lungs or other organs by combining with hydroxypropyl-beta-cyclodextrin | UNIVERSITY OF FLORIDA (US) | 1991-01-08 | — | — | US | claimed |
| EP-0359347-A2 | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging | NEORX CORPORATION (US) | 1990-03-21 | — | — | EP | claimed |
| EP-0335545-A2 | Pharmaceutical formulations for parenteral use | UNIVERSITY OF FLORIDA (US) | 1989-10-04 | — | — | EP | claimed |
| EP-0092709-B1 | PROCESS FOR PRODUCING L-HYSTIDINE BY FERMENTATION AND MICROORGANISMS THEREFOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1987-07-29 | — | — | EP | claimed |
| US-4495283-A | Process for producing L-histidine by fermentation | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-01-22 | — | — | US | claimed |
| EP-0092709-A2 | Process for producing L-hystidine by fermentation and microorganisms therefor | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1983-11-02 | — | — | EP | claimed |